Correlative study on neuro‐endocrine differentiation and presence of somatostatin receptors in breast carcinomas

International Journal of Cancer

Volumn 43, Issue 3, 1989, Pages 365-369

  Papotti, M ^a   Macri, L ^b   Bussolati, G ^a   Reubi, J C ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b Sant'Anna Hospital   (Italy)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; SOMATOSTATIN RECEPTOR;

BREAST CARCINOMA; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOGRANINS; FEMALE; HUMAN; IMMUNOENZYME TECHNIQUES; MEMBRANE PROTEINS; MIDDLE AGE; PHOSPHOPYRUVATE HYDRATASE; RECEPTORS, ESTROGEN; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0024563573     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910430302     Document Type: Article

References (34)

1. Argyrophilic and endocrine cells in breast cancer
2. “carcinoid” tumours of the breast: the morphological spectrum of argyrophilic carcinomas
3. Iso‐Enzyme pattern of enolase in the diagnosis of neuro‐Endocrine bronchopulmonary tumors
4. Synaptophysin immunoreactivity and small clear vesicles in neuro‐Endocrine cells and related tumours
5. Argyrophilic breast carcinoma (letter to the editor)
6. Chromogranin reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast
7. Endocrine markers in argyrophilic carcinomas of the breast
8. Endocrine differentiation in mucoid carcinoma of the breast
9. Argyrophilic breast carcinomas. Evidence of lactational differentiation
10. Primary carcinoid tumour of the breast: a report of eight patients
11. Multidirectional differentiation in neuro‐Endocrine neoplasms
12. Neuro‐Endocrine differentiation in prostatic carcinoma
13. Über die carcinoide Wuchsform der Carcinoma mammae, insbesondere das Carcinoma solidum (gelatinosum) mammae
14. Neuro‐Endocrine tumors in “miscellaneous” primary sites: clinical, pathologic, and histogenetic implications
15. Fixation methods alter the immunohistochemical demonstrability of synaptophysin
16. Synaptophysin: a novel marker for neurons, certain neuro‐Endocrine cells, and their neoplasms
17. 2 cells in human pancreatic islets
18. A shorter immunoperoxidase of carcino‐Embryonic‐Antigen and other cell products
19. Use of avidin‐Biotin‐Peroxidase complex (aBC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (pAP) procedures
20. Potential role of somatostatin analogues in the treatment of cancer
21. Immunocytochemical evidence for neuro‐Endocrine differentiation in human breast carcinomas
22. Neurone‐Specific enolase immunostaining in the diagnosis of breast carcinomas with neuro‐Endocrine differentiation. Its usefulness and limitations
23. A study of different markers for neuro‐Endocrine differentiation in breast carcinomas
24. Secretion of chromogranin A by peptide‐Producing endocrine neoplasms
25. Hormone‐Producing gastro‐Intestinal tumors contain high density of somatostatin receptors
26. Visualization of somatostatin receptors and correlation with immunoreactive GH and PRL in human pituitary adenomas. Evidence for different tumor subclasses
27. High density of somatostatin receptors in pituitary adenomas from acromegalic patients
28. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system
29. High incidence of somatostatin receptors in human meningiomas: biochemical characterization
30. Somatostatin receptors in human endocrine tumors
31. Distinct topographical localization of two somatostatin receptor subpopulations in the human cortex
32. Comparison of chromogranin A and B and secretogranin II in human adrenal medulla and pheochromocytoma
33. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells
34. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids